Halo Collective (BST:A9KN) - Aandelenkoers, Nieuws & Analyse

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

A9KN Overzicht aandelen

Engages in the cultivation, manufacture, transportation, and distribution of cannabis and cannabis extracts in Canada and the United States.

Over het bedrijf

A9KN fundamentele analyse
Sneeuwvlok Score
Waardering	2/6
Toekomstige groei	0/6
Prestaties in het verleden	0/6
Financiële gezondheid	6/6
Dividenden	0/6

Beloningen

Risicoanalyse

De winst is de afgelopen 5 jaar met 48.7% per jaar gedaald

Heeft geen betekenisvolle marktkapitalisatie ( €1M )

Aandeelhouders zijn het afgelopen jaar substantieel verwaterd

Aandelen zijn zeer illiquide

Halo Collective Inc. Concurrenten

Biofrontera

XTRA:B8FK

€14.5m

SynBiotic

DUSE:SBX

€30.5m

Redx Pharma

DB:0RX

€65.0m

Cantourage Group

XTRA:HIGH

€63.6m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Halo Collective
Historische aandelenkoersen
Huidige aandelenkoers	US$0.26
52 Week Hoogtepunt	US$4.07
52 Week Laag	US$0.066
Bèta	1.96
11 maand verandering	0%
3 maanden verandering	229.30%
1 Jaar Verandering	-93.17%
33 jaar verandering	-99.68%
5 jaar verandering	n/a
Verandering sinds IPO	-99.83%

Recent nieuws en updates

Recent updates

Rendement voor aandeelhouders

	A9KN	DE Pharmaceuticals	DE Markt
7D	0%	1.7%	1.8%
1Y	-93.2%	-11.1%	13.8%

Rendement versus industrie: A9KN presteerde slechter dan de German Pharmaceuticals -sector, die het afgelopen jaar een rendement van -11.1 % opleverde.

Rendement versus markt: A9KN presteerde slechter dan German Market, dat het afgelopen jaar een rendement van 13.8 % opleverde.

Prijsvolatiliteit

Is A9KN's price volatile compared to industry and market?
A9KN volatility
A9KN Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	5.4%
Market Average Movement	5.0%
10% most volatile stocks in DE Market	11.1%
10% least volatile stocks in DE Market	2.4%

Stabiele aandelenkoers: De aandelenkoers van A9KN is de afgelopen 3 maanden volatiel geweest.

Volatiliteit in de loop van de tijd: Onvoldoende gegevens om de volatiliteitsverandering van A9KN in het afgelopen jaar te bepalen.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
2016	276	Katie Field	www.haloco.com

Halo Collective Inc. Samenvatting

Hoe verhouden de winst en inkomsten van Halo Collective zich tot de beurswaarde?
A9KN fundamentele statistieken
Marktkapitalisatie	€1.10m
Inkomsten(TTM)	-€87.07m
Inkomsten(TTM)	€26.08m

0.0x

P/S-verhouding

0.0x

Koers/Winstverhouding

Is A9KN overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
A9KN resultatenrekening (TTM)
Inkomsten	US$28.34m
Kosten van inkomsten	US$24.54m
Brutowinst	US$3.80m
Overige uitgaven	US$98.41m
Inkomsten	-US$94.61m

Laatst gerapporteerde inkomsten

Sep 30, 2022

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	-1.39
Brutomarge	13.40%
Nettowinstmarge	-333.86%
Schuld/Eigen Vermogen Verhouding	18.3%

Hoe presteerde A9KN op de lange termijn?

Bekijk historische prestaties en vergelijking

A9KN Overzicht aandelen

Beloningen

Risicoanalyse

Halo Collective Inc. Concurrenten

XTRA:B8FK

€14.5m

DUSE:SBX

€30.5m

DB:0RX

€65.0m

XTRA:HIGH

€63.6m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Halo Collective Inc. Announces Change to Board of Directors

Halo Collective Inc. Announces Expansion of Cannabis Genetics and Strain Portfolio, Specifically Within Its Oregon Operations

Halo Collective Inc., Annual General Meeting, Mar 24, 2023

Halo Collective Inc. announced that it has received $6.99999 million in funding from Agilent Technologies, Inc., Research Corporation Technologies, BroadOak Capital Partners LLC, Investment Arm, BioAdvance, and other investors

Halo Collective Inc. Announces Launch of New Premium Cannabis Strains

Second quarter 2022 earnings released: US$1.61 loss per share (vs US$11.41 loss in 2Q 2021)

Recent updates

Halo Collective Inc. Announces Change to Board of Directors

Halo Collective Inc. Announces Expansion of Cannabis Genetics and Strain Portfolio, Specifically Within Its Oregon Operations

Halo Collective Inc., Annual General Meeting, Mar 24, 2023

Halo Collective Inc. announced that it has received $6.99999 million in funding from Agilent Technologies, Inc., Research Corporation Technologies, BroadOak Capital Partners LLC, Investment Arm, BioAdvance, and other investors

Halo Collective Inc. Announces Launch of New Premium Cannabis Strains

Second quarter 2022 earnings released: US$1.61 loss per share (vs US$11.41 loss in 2Q 2021)

Halo Collective Inc. Appoints Katie Field as Chairman of the Board

Halo Collective Receives All Regulatory Approvals for Its Third Budega Dispensary in Hollywood, Halo's First Superstore

Halo Collective Inc. announced that it has received $6 million in funding from Agilent Technologies, Inc., Research Corporation Technologies, BroadOak Capital Partners LLC, Investment Arm, BioAdvance and other investors

Halo Collective Inc. announced that it has received $5.999994 million in funding

Halo Collective Inc. Announces Management Changes

First quarter 2022 earnings released: US$0.28 loss per share (vs US$0.56 loss in 1Q 2021)

Halo Collective Inc. Announces Resignation of Philip Van Den Berg as Chief Financial Officer

Halo Collective Inc. Receives Final Approvals from the Los Angeles Department of Cannabis Regulation & California Department of Cannabis Control and the State Department of Cannabis Control

High number of new directors

Full year 2021 earnings released: US$4.12 loss per share (vs US$7.27 loss in FY 2020)

Less than half of directors are independent

Halo Collective Announces Changes to Board of Directors

Halo Collective Inc. Receives All Approvals for Budega™ Dispensary in North Hollywood, California

Halo Collective Inc. Receives All Approvals for Budega™ Dispensary in North Hollywood, California

Halo Collective Inc. (OTCPK:HCAN.F) completed the acquisition of 1285826 B.C. Ltd. from 1337617 B.C. Ltd., 1253540 B.C. Ltd. and NKG Investments Ltd.

Halo Collective Inc. announced that it expects to receive CAD 14 million in funding from Alpha Blue Ocean Investment Group

Halo Collective Receives Local Approvals for Budega™ Dispensary in Los Angeles's Noho Arts District

Halo Collective Inc. (OTCPK:HCAN.F) entered into an agreement to acquire 1285826 B.C. Ltd. for $7 million.

Third quarter 2021 earnings released: US$0.40 loss per share (vs US$0.42 loss in 3Q 2020)

High number of new directors

High number of new directors

Halo Collective Inc. Announces the Official Launch of Ztrawberriez and 4 Prophets Premium Cannabis Flower

Halo Collective Inc. Announces FlowerShop, a Sensory-Care™ Brand Launches New Product Line, BUDVASE

Halo Collective Announces Reorganization of International Assets to Create Akanda

Halo Collective Inc. Provides Earnings Guidance for the Year 2021

Halo Collective Inc. Provides Sales Guidance for the Month Ended April 2021

Halo Collective Inc. announced that it expects to receive CAD 1 million in funding

Halo Collective Inc. has completed a Composite Units Offering in the amount of CAD 10.000025 million.

PeakBirch Logic Inc. Announces Partnership with Halo Collective Inc. to Develop Functional Mushroom Line

Halo Collective Inc. Enters into Partnership with Nightingale Remedies (Nightingale) and PeakBirch Logic Inc

Halo Collective Inc. has completed a Composite Units Offering in the amount of CAD 8.00154 million.

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of 1275111 B.C. Ltd.

Halo Labs Inc. announced that it expects to receive CAD 2.25 million in funding

Chief Financial Officer recently sold €95k worth of stock

Red Light Holland and Halo Labs Announce Intention to Enter Oregon Medicinal Psilocybin Market

Third quarter 2020 earnings released: US$0.006 loss per share

Halo Labs Inc. Appoints Annmol Sidhu to the Board of Directors

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of CanMart Ltd from David Keith Dean and Darran William Quinn.

Fred Leigh Resigns to Halo Labs Inc.'s Board of Directors

Halo Labs Inc. (OTCPK:AGEE.F) entered into a binding Letter of Intent to acquire CanMart Ltd for CAD 4.6 million.

Halo Labs Inc. (OTCPK:AGEE.F) entered into an amended asset purchase agreement to acquire three operating KushBar retail cannabis stores from KushBar Inc. for CAD 3.4 million.

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of 1265292 B.C. Ltd.

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of the remaining 85.28% stake in Ukiah Ventures Inc. from Odyssey Trust Company and others.

Earnings released

Halo Labs Inc. (OTCPK:AGEE.F) entered into a share exchange agreement to acquire the remaining 85.28% stake in Ukiah Ventures Inc. for $6.5 million.

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of 66.7% stake in LKJ11 LLC.

Halo Labs Inc. (OTCPK:AGEE.F) entered into a binding agreement to acquire a dispensary in Los Angeles.

Rendement voor aandeelhouders

Prijsvolatiliteit

Over het bedrijf

Halo Collective Inc. Samenvatting

0.0x

0.0x